Name:
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
Type:
Benzodiazepine
AKA:
Etodesnitazene; etazene
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine image
Synthetic substance, no natural derivative
IUPAC Logo
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine image
Etizolam, a thienodiazepine, was first developed in the 1980s. It was introduced as an anxiolytic and hypnotic medication, offering similar effects to benzodiazepines but with a different chemical structure. The compound gained popularity in various countries for its effectiveness in treating anxiety and sleep disorders. Etizolam's use has been subject to regulatory controls due to dependence potential.
Synthetic Substances Image
Etizolam is a benzodiazepine with anxiolytic and sedative properties. It causes sedation and muscle relaxation, acting as a downer. Short-term use is effective for managing anxiety and insomnia, while long-term use can lead to dependence and cognitive issues. Overdose risks include severe sedation and respiratory depression. Safe use involves following prescribed dosages and regular medical supervision. Recent research highlights its effectiveness in treating anxiety and its safety profile.
N/A
Etizolam, a thienodiazepine, provides sedation and anxiety relief. Immediate effects include reduced anxiety and mood stabilization. Long-term use may lead to dependence, tolerance, and cognitive impairments. Chronic use is associated with mood disorders and potential addiction. Recent research highlights its effectiveness in treating anxiety but also emphasizes the risks of long-term use and cognitive effects.
N/A
Etizolam is a thienodiazepine with anxiolytic and sedative properties, classifying it as a downer. Short-term use reduces anxiety and induces sleep, while long-term use can lead to dependence and withdrawal symptoms. Overdose risks include severe respiratory depression and potentially fatal outcomes. Safe dosages are medically prescribed, typically under 3 mg per day. Recent research highlights its efficacy in anxiety and insomnia management but warns of addiction risks. Physical effects include drowsiness, dizziness, and impaired coordination.
N/A